Archive for February 21st, 2012

GTXI Capesaris placed on clinical hold. RGEN PDUFA date. TRGT added to database + CHTP THLD ANTH GENT news

Feb 21, 2012 No Comments by

Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) briefing materials are now available HERE. The meeting will be held on Thursday, February 23, 2012 to review NORTHERA for the treatment of symptomatic neurogenic orthostatic hypotension. GTx, Inc. (Nasdaq: GTXI) announced that its clinical trials evaluating Capesaris (GTx-758) for primary (first line) androgen deprivation therapy for [...]

Daily News Read more

 

February 2012
M T W T F S S
« Jan   Mar »
 12345
6789101112
13141516171819
20212223242526
272829  

Recent Comments

Latest Articles

Chatroom has been upgraded – Live now!!

Dear BioPharmCatalyst reader, I am pleased to announce that the chatroom has had a complete revamp for the benefit of all users of BioPharmCatalyst. The previous chatroom was admittedly poorly designed and as a result received little attention. It was not user-friendly and in fact most readers were unaware it existed. However, as of today [...]

NBIX releases Phase 2 data. NBY and SPPI initiate Phase 2 trials

Spectrum Pharmaceuticals (NasdaqGS: SPPI) announced the initiation of a Phase 2 trial of ZEVALIN for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin’s lymphoma (NHL). Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced efficacy and safety results from its Phase 2 trial of urocortin 2 in 53 patients [...]

Abstracts have been added to the ASCO Calendar!

Earlier today abstracts to next month’s ASCO meeting were released. Approximately 75 of those abstracts can now be found in the BioPharmCatalyst ASCO Calendar, which can be found HERE. Session times and other information can also be found to give you a one-stop resource provided to save you much time in searching for abstracts.

Sign up me up now!

For content updates enter your email address below.

Login

Video

Biopharmcatalyst.com: FDA Calendar for investors in US pharmaceutical companies

» BioPharmCatalyst Channel

Latest Tweet

Polls